Here, we showed that yeast cells expressing RAG1 variants with pathogenic mutations demonstrated a decreased level of recombination rate that correlated with disease severity, expanding the use of yeast models towards immunodeficiencies. This evidence concerns the gene RAG1 and immune system disorder.